Rare / orphan disease drugs

Company Drug

CANbridge Pharmaceuticals Presents Positive Phase I Data for CAN106 at EHA Congress

Fineline Cube Jun 13, 2022

China-based rare disease firm CANbridge Pharmaceuticals Inc. (HKG: 1228) released the latest data from a...

Company Drug

Wenda Pharmaceutical Secures NMPA Breakthrough Therapy Designation for NHWD-870 in Rare NUT Carcinoma

Company Drug

European Commission Approves Bristol Myers Squibb’s Sotyktu for Psoriatic Arthritis Following FDA Clearance

Company Deals

CureGene Pharmaceutical Secures RMB 300 Million Series C to Advance Global Clinical Pipeline

Company Drug

Keymed Biosciences Secures NMPA Breakthrough Therapy Designation for CM336 in AL Amyloidosis